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types in response to environmental conditions. Such plasticity can be manifest at the level of indi-
vidual cells, an organ, or a whole organism. Imprinted genes are a group of approximately 100 genes
with functionally monoallelic, parental-origin speciﬁc expression. As imprinted genes are critical for
prenatal growth and metabolic axis development and function, modulation of imprinted gene dos-
age has been proposed to play a key role in the plastic development of the unborn foetus in response
to environmental conditions. Evidence is accumulating that imprinted dosage may also be involved
in controlling the plastic potential of individual cells or stem cell populations. Imprinted gene dos-
age can bemodulated through canonical, transcription factor mediated mechanisms, or through the
relaxation of imprinting itself, reactivating the normally silent allele.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Developmental plasticity
Developmental plasticity can be deﬁned as the ability of one
genotype to produce a range of phenotypes in response to environ-
mental conditions. Such plasticity can be manifest at the level of
individual cells, an organ, or a whole organism. The totipotent zy-
gote represents the pinnacle of cellular developmental plasticity
and as the embryo develops, lineage restriction events reduce the
developmental potential of subpopulations of cells such that cellu-
lar plasticity declines with developmental age. Epigenetic modiﬁ-
cations, which can be deﬁned as ‘the structural adaptation of
chromosomal regions so as to register, signal or perpetuate altered
activity states [1], play a key role in stabilising these lineage
restriction events. Consequently, the reacquisition of developmen-
tal potential, as occurs naturally during germ cell development and
fertilisation and artiﬁcially during cloning or during the generation
of induced pluripotent stem cells (iPSCs), requires extensive epige-
netic reprogramming. This includes the reprogramming of epige-
netic marks at imprinted loci.
2. Genomic imprinting
Imprinted genes are a unique class of approximately 100 genes
which are expressed predominantly from one chromosome in a
parental-origin dependent manner (Fig. 1). Imprinted genes are
not distributed uniformly through the genome, but are often found
in clusters where the parental allele-speciﬁc pattern of genecal Societies. Published by Elsevier
Ferguson-Smith).expression is coordinately regulated by imprinting control regions
(ICRs) through long-range cis-acting mechanisms. ICRs are charac-
terised by differing epigenetic marks on the two parentally inher-
ited chromosomes [2]. DNA methylation and the post-translational
modiﬁcation of core histones are important epigenetic modiﬁca-
tions and these play key roles in imprinting control. To date, all
ICRs identiﬁed are differentially DNA methylated regions (DMRs)
on the two parental chromosomes. These differential methylation
marks are acquired in the developing oocytes and sperm and, in
normal circumstances, are heritably maintained after fertilization
in the developing embryo and throughout life. Secondary or so-
matic DMRs, found at some imprinted promoter regions, acquire
their parental-origin speciﬁc methylation post-fertilisation. This
requires the gametic ICR and is thought to reinforce imprinted
gene expression (Fig. 1, [3]). The role of histone modiﬁcations in
imprinting control is less clear, however DMRs are characterised
by the asymmetrical accumulation of different histone modiﬁca-
tions on the two parental chromosomes and recently a require-
ment for histone demethylation in order to establish germline
CpG methylation has been identiﬁed at some ICRs [4].
The existence of parental-origin speciﬁc DMRs necessitates a
process of epigenetic reprogramming during gamete development
such that germ cells exhibit the appropriate epigenetic marks at
ICRs to ensure the successful development of future offspring
(Fig. 1). This begins after the primordial germ cells (PGCs) have
been speciﬁed at E7.5 and continues throughout the migration of
the PGCs to the genital ridge. A second wave of demethylation oc-
curs around E11.5 and includes the dramatic and rapid erasure of
methylation at imprinted loci [5]. Dogma dictates that this
demethylation is complete, and that there is no epigeneticB.V. Open access under CC BY-NC-ND license.
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Fig. 1. Reprogramming of imprinting control regions during development. The existence of parental-origin speciﬁc DMRs necessitates a process of epigenetic reprogramming
during gamete development such that germ cells exhibit the appropriate epigenetic marks at ICRs to ensure the successful development of future offspring. This begins after
the primordial germ cells (PGCs) have been speciﬁed at E7.5 and continues throughout the migration of the PGCs to the genital ridge. A second wave of demethylation occurs
around E11.5 and includes the dramatic and rapid erasure of methylation at imprinted loci (reviewed by Sasaki and Matsui [5]).
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intra-cisternal A particles, can partially escape this methylation
reprogramming [6,7].
Imprinted genes have been proposed as key modulators of
organismal developmental plasticity, but there is also evidence
for their involvement in the plasticity of organs and single cells.
There are two mechanisms through which the expression of an im-
printed gene may be modulated: through a canonical, transcription
factor driven mechanism (Fig. 2A), or through the modulation of
imprinting itself (Fig. 2B). Imprinted genes are not universally
mono-allelically expressed, rather the umbrella classiﬁcation ofbPat
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Fig. 2. Mechanisms of imprinted gene dosage regulation. Imprinted gene dosage may b
where expression from the normally expressed allele is upregulated (A); or through the
Loss of imprinting may involve a single gene in an imprinted cluster (B) or the whole locu
often associated with changes in epigenetic marks at imprinting control elements or se‘‘imprinted’’ conceals an extraordinary variety of temporal and
tissue speciﬁcity of mono-allelic expression and, for some genes,
inter-individual heterogeneity [8,9]. Our understanding of what
initiates mono-allelic expression remains sketchy, although in
some cases this coincides with differentiation events which restrict
cellular developmental potential. Altered imprinted gene dosage
through loss of imprinting, the activation of the normally silent al-
lele, or the silencing of the normally active allele of an imprinted
gene has been observed in various pathological states, however it
remains unclear whether this is utilised as a mechanism of dosage
control during normal development.c
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relaxation or loss of imprinting, where the normally silent allele is reactivated (B).
s (C), with coordinate changes in expression of reciprocally imprinted genes. This is
condary DMRs.
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3.1. Imprinting dynamics in early development and in stem cells
Because the derivation and in vitro culture of embryonic stem
(ES) cells are potential points of origin for epigenetic abnormalities,
the epigenetic status of all stem cells and their derivatives must be
established prior to their therapeutic use in humans. Recently, in-
duced pluripotent stem cells (iPSCs) have been generated by the
forced over-expression of deﬁned sets of transcription factors in
human somatic cells [10–12]. iPSCs hold great potential for the
study of genetic diseases and to be a source of patient-speciﬁc stem
cells for regenerative medicine therapies. Consequently the rigor-
ous characterisation of these cells, including the epigenetic and
expression status of imprinted loci, is of paramount importance.
It remains unclear whether iPSCs are molecularly and functionally
equivalent to blastocyst-derived ES cells. Recently a controversial
study showed overall messenger RNA and microRNA expression
patterns to be indistinguishable between murine iPSCs and ES cells
with the exception of the aberrant silencing in some iPSC lines of
the non-coding RNA transcripts of the imprinted Dlk1-Dio3 domain
on chromosome 12qF1 [13]. This was associated with reduced
contribution to chimaeras and a failure to produce viable all-iPSC
derived mice, implying that expression of these imprinted
non-coding RNAs is required for full developmental plasticity.
While this study is compromised because restoration of expression
and rescue of the phenotype was not conducted, it has reignited
the debate on imprinting status and its functional implications
during early development and in stem cell models.
Evidence is accumulating for the relaxation of imprinting in the
stem cell niche of some tissues. Our recent work on the role of the
Dlk1-Dio3 locus in adult neurogenesis suggests that the selective
modulation of imprinting is a normal mechanism of altering gene
dosage and is associated with the control of developmental poten-
tial in the adult neurogenic niche [14]. We demonstrate that during
early postnatal life, the normally silent maternal copy of Dlk1 is
derepressed speciﬁcally in the multipotent stem cells of the neuro-
genic niche [14]. This is associated with the partial gain of methyl-
ation at the imprinting control region of this locus, the IgDMR.
Interestingly, imprinting of Gtl2, a maternally expressed non-cod-
ing RNA in the same cluster is unaffected, and differential methyl-
ation of a secondary DMR at the Gtl2 promoter is maintained.
Differentiation of adult neural stem cells both in vivo and in vitro
is associated with the reacquisition of imprinting at Dlk1. These
data force us to reconsider imprinting control mechanisms and
the role of imprinting in developmental plasticity. However, it is
currently unknown how many stem cell populations and im-
printed genes behave in this way, and how mechanistically such
dynamic imprinting modulation is achieved.
While the body of data on the tissue and temporal-speciﬁcity of
imprinting at many loci is growing, the expression and imprinting
status of imprinted genes during very early embryonic develop-
ment remains largely uncharacterized. The emergence of monoall-
elic expression occurs at different developmental stages at
different loci and also varies between different genes within a sin-
gle imprinted locus. Data acquired from the study of undifferenti-
ated ES cells derived from the pluripotent inner cell mass of the
blastocyst have been used as an in vitro model of early develop-
ment which complements in vivo data. This has revealed that at
some loci the acquisition of mono-allelic expression occurs in tan-
dem with differentiation or lineage restriction events. In undiffer-
entiated ES cells equal expression has been shown from both Igf2r
promoters. Differentiation is associated with the gain of imprinting
at the Igf2r locus through the speciﬁc upregulation of expression
from the maternally inherited allele [15]. In the early embryo, Igf2ris biallellically expressed from the 4 cell stage up to and including
the blastocyst stage. Monoallelic expression is gained from E4.5-
E6.5 and is dependent on the expression of the overlapping non-
coding RNA Airn. Imprinting at the Kcnq1 cluster is also dependent
on the expression of a non-coding RNA from the paternally inher-
ited allele, Kcnq1ot1. In contrast to Airn, Kcnq1ot1 is paternally ex-
pressed in preimplantation embryos from the two-cell stage.
Genes located close to Kcnq1ot1 are ubiquitously imprinted, and
monoallelic expression is already detected in blastocysts and
undifferentiated ES cells [16,17]. More distal genes are imprinted
only in the extra-embryonic tissues and restriction of expression
to one parentally-inherited allele coincides with trophoblast spec-
iﬁcation [17].
Together these data lead us to suggest that imprinting is a
mechanism of dosage control which may, in some instances, be
associated with the control of developmental potential. The careful
study of the dynamics of imprinted gene expression at deﬁned
lineage restriction decisions in different cell populations and dif-
ferent developmental stages during in vivo development and
in vitro differentiation and derivation are now required to test
how widespread or rare such a strategy is.
3.2. Perturbation of imprinted gene dosage is associated with
neoplastic transformation
Another interesting model in which to interrogate the role of
imprinted genes in cellular plasticity is provided by cancer cells
which are characterised by an abnormal gain in developmental po-
tential. The importance of epimutation in cancer is increasingly
being recognised. Indeed, some consider cancer to be as much an
epigenetic disease as it is a genetic disease [18]. Many imprinted
genes play roles in cellular growth and proliferation and conse-
quently there may be selective pressure for their deregulation in
cancer cells. Loss of imprinting (LOI) has been reported to be the
most abundant alteration in some cancers and tends to be an early
event in neoplastic transformation, demonstrating the importance
of imprinted dosage in the maintenance of cellular and tissue iden-
tity [19–21]. Indeed, patients with congenital imprinting syn-
dromes and deregulated imprinted gene dosage have an
increased risk of cancer [22,23]. The gene encoding the insulin-like
growth factor II (IGF2) and the H19 gene (a putative tumor sup-
pressor gene) are imprinted in humans and expressed from the
paternally inherited and maternally inherited allele respectively.
Studies in solid tumours showed that the biallelic expression of
IGF2 in gliomas and invasive breast cancers is associated with the
aggressiveness of tumour growth [21]. There is evidence that LOI
may predate and predispose to carcinogenesis, potentially by
retarding cellular differentiation and derepressing developmental
and proliferative potential (Fig. 3). Igf2 imprinting is lost in the co-
lonic mucosa of 10% of the population and is associated with a per-
sonal and/or family history of colonic adenocarcinoma [24]. A
murine Igf2 LOI model recapitulates the altered morphology of
the normal colonic mucosa seen in patients with IGF2 LOI: an in-
creased proportion of undifferentiated cells and expanded colonic
crypts in the absence of proliferative changes [25]. This is associ-
ated with an increased incidence of colon cancer, strongly suggest-
ing that LOI at the IGF2 locus promotes neoplastic transformation.
While much literature documents LOI during neoplastic trans-
formation, reports of transcription-factor mediated deregulation
of imprinted gene expression in these processes is also growing.
Imprinting is generally maintained at the DLK1-DIO3 locus in tu-
mours, however, a variety of neuroendocrine and glial tumours
are characterised by high levels of DLK1 expression, implicating
dosage perturbation via a transcription-factor mediated mecha-
nism [26]. A recent in vitro analysis found hypoxia-mediated
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Fig. 3. Imprinting, the stem cell niche and neoplastic transformation. There is evidence to suggest that the highly regulated modulation of imprinting in the stem cell
population of some tissues may play an important role in the control of cellular developmental potential. However, further genetic or epigenetic change in this stem cell
population may result in the deregulation of proliferation and neoplastic transformation.
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tumourigenic potential and reduced differentiation [27], support-
ing the hypothesis that imprinted gene dosage may be related to
tumorigenesis and malignant transformation (Fig. 3).
In each organ there exists a stem cell population which replen-
ishes the cells of that organ through asymmetrical divisions, one
cell remaining a stem cell while the other differentiates [28]. Sev-
eral reports indicate that LOI in tissue-speciﬁc stem cells may
cause the population to abnormally proliferate and expand
[20,25,29]. Stem cells and cancer cells commonly share gene
expression patterns, regulatory mechanisms, and signalling path-
ways. This has led to ‘‘the cancer stem cell hypothesis’’ which
suggests that tumours arise from stem cell populations with dys-
regulated self-renewal caused by epigenetic and/or genetic initiat-
ing events, resulting in abnormal expansion and aberrant
differentiation [25,30], (Fig. 3). Furthermore, tumour cell heteroge-
neity has been proposed to be due in part to epigenetic variation
and epigenetic plasticity in these progenitor cells [31]. As
discussed above, there is evidence for the relaxation of imprinting
in the stem cell niche of some tissues [14]. The mechanisms
involved in regulating such selective relaxation of imprinting are
almost entirely unknown, but are of potentially great importance
to our understanding of how cellular developmental potential is
controlled and the processes underlying neoplastic transformation.
4. Developmental plasticity of a whole organism
Organism developmental plasticity, the adaptivemodiﬁcation of
developmental phenotype in response to environment, can result
in astonishing phenotypic diversity. For example, polyphenism in
invertebrates produces the colourfully different dry and wet season
morphs of certain butterﬂies [32] or the sexual, asexual, winged
and wingless forms of the pea aphid [33]. In mammals there is
increasing recognition of the power of the environment during pre-
natal development to shape adult growth, metabolism and behav-
ioural phenotype. Indeed, studies on laboratory mice have shown
that environmental inﬂuences can be a greater determinant of
phenotype than genetic variation [34]. The study of genetically
identical inbred mouse strains essentially eliminates inter-
individual genetic variation, consequently any inter-individual
phenotypic variation must stem from epigenetic differences.
As imprinted genes are crucial for reproductive and maternal
behaviour, embryonic growth and the development and function
of key metabolic axes (Fig. 4), they have been proposed as candi-
dates to play a key role in mammalian developmental plasticity.
It has also been hypothesised that, as the expression of imprinted
genes is functionally monoallelic, exquisitely dosage sensitive and
controlled by multiple layers of epigenetic regulation, imprintingand imprinted gene dosage may be more susceptible to environ-
mental changes which impinge on the normal function of the cel-
lular epigenetic apparatus [35]. However, we propose that the
converse may instead be true: given the dependence of imprinted
gene expression on epigenetic modiﬁcations, these may be more
tightly safeguarded in the face of environmental perturbations dur-
ing development and any mechanism which requires the action of
the canonically repressed allele is likely to be highly regulated.
Proper investigation of these hypotheses requires the analysis of
how the expression of imprinted genes, as a class, responds to
environmental challenge relative to the whole transcriptome and
to other functionally related gene sets. In the absence of such anal-
yses in the published literature we review the existing data on the
stability of imprinted gene dosage and the epigenetic status of im-
printed DMRs to environmental challenge during early life.
4.1. The role of imprinted genes in developmental plasticity in response
to peri-conception environmental challenges
As the penultimate carbon donor to the methyltransferase en-
zymes is the essential amino acid methionine, diet may impinge
on methyl-group availability for biological processes, including
epigenetic modiﬁcations. It has been proposed that nutritional
availability around conception may affect the post-fertilisation
wave of epigenetic reprogramming [36,37]. Multiple studies of em-
bryos fertilised and cultured in vitro have suggested that imprint-
ing control elements may be more susceptible to the
environment during this period than previously thought [38,39].
However, these studies are potentially confounded by the effects
of superovulation, which has been shown to alter the epigenetic
status of maternal ICRs [40].
There is some evidence of an association of peri-conception
famine exposure with increased susceptibility to cardiovascular
disease and earlier disease onset [41,42]. Exposure at this time
point has been associated with subtle changes in methylation at
three DMRs in different imprinted clusters in blood samples of af-
fected versus unaffected sibs. However, the functional signiﬁcance
of this is unclear as leukocyte methylation is notoriously variable
and the studies did not examine any associated expression
changes, effects on imprinting, or attempt any correlation with
known phenotypic outcomes [43,44]. In a rat model of peri-
implantation low protein diet Kwong et al. [36,37] demonstrated
a male-speciﬁc reduction in birth weight and development of
hypertension at a young age, associated with a 30% reduction in
male blastocyst H19 expression. While methylation at the H19
DMR was slightly altered [37], it did not correlate with the ob-
served change in expression, indicating that it was not mechanis-
tically responsible and, although not directly tested, imprinting
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Fig. 4. Imprinted genes are critical for the control of energy balance. The correct imprinted gene expression dosage is vital for energy homeostasis during both prenatal and
postnatal life. Imprinted genes play critical roles in the control of foetal nutrient supply through effects on maternal metabolism and energy partitioning, placental
development and function. There is also evidence that imprinted genes act coordinately in the foetus to regulate growth, thus altering foetal demand for maternal resources.
Imprinted genes play key roles in the development of metabolic organs and modulate key adult metabolic pathways. Adapted from Charalambous et al. [66]
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a subtle reduction in H19 expression during early development are
unknown. In summary, although in vitro studies provide some evi-
dence that the epigenetic status of DMRs in the early embryo is la-
bile and susceptible to culture conditions, there is currently little
evidence for this from in vivo studies.
4.2. The role of placental imprinted gene expression in developmental
plasticity
The placenta controls nutrient supply to the foetus, is the site of
foeto-maternal interaction and is a highly active endocrine tissue,
secreting factors which alter maternal metabolism and behaviour
[45,46]. The placenta is also a highly plastic organ, responsive to
foetal demand for resources [47]. Alterations in placental develop-
ment can therefore have a dramatic effect on foetal growth; in-
deed, placental insufﬁciency is a leading cause of intra-uterinegrowth restriction in the developed world. Imprinted genes play
key roles in placental growth, patterning and function and in the
coordination of foetal resource demand and maternal supply, as
exempliﬁed by analysis of the Peg3 and Igf2mutants [48–50]. Con-
sequently several studies have sought to address whether deregu-
lation of placental imprinted gene expression is associated with
human developmental programming and intra-uterine growth
restriction.
The maternally expressed Phlda2/Ipl acts to restrain placental
growth while the paternally expressed Mest promotes it [51,52].
Apostolidou et al. [53] screened 200 human placentas by qPCR
for PHLDA2, IGF2, IGF2R and MEST. Only PHLDA2 expression signif-
icantly correlated (negatively) with birth weight, but imprinting
was not affected, implicating a transcription factor mediated
mechanism. In contrast, McMinn et al. [54] assessed the transcrip-
tome of a small sample of human IUGR and normal placentas and
observed increased expression of PHLDA2 and decreased MEST,
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methylation changes at the PHLDA2 or MEST ICRs, nor were the
spatial distribution of PHLDA2 expression changed. Imprinted
genes constituted 7% of their expression changes, a signiﬁcantly
higher proportion than would be expected, potentially implicating
imprinted genes as a class as playing a key role in human IUGR.
However, morphological adaptations occur in small placentas in
an effort to sustain foetal growth [47] and thus the observed
expression changes may be indirect, reﬂecting a secondary effect
of the altered morphology.
In human studies much effort has focussed on establishing
whether circulating foetal IGF2 levels correlate with foetal growth.
However, the evidence is conﬂicting, as a variety of studies which
have found that IGF2 levels in the placenta and/or cord blood cor-
relate positively with birth weight [55–59], while others ﬁnd no
such relationship [60–64]. The discrepancies may partly be due
to a failure to take into account the impact of changes in the levels
of the circulating non-imprinted binding proteins which alter IGF2
bioavailability, IGFBPs. Serum level of several IGFBPs has been
found to correlate with birth weight and may be modulated by in
utero nutrition [57,58,61,65]. This relationship with proteins which
modulate bioavailability makes Igf2 a particularly challenging
model for assessing phenotypic plasticity and imprinted gene dos-
age and also suggests that the effective dosage of imprinted genes
may be modulated post transcriptionally by non-imprinted
pathways.
In summary, while there is some evidence of altered placental
imprinted gene dosage in IUGR, there is no evidence that this in-
volves changes in the epigenetic status of imprinted DMRs sug-
gesting that transcription factor-mediated dosage modulation is
responsible. Therefore, there is currently little evidence to suggest
that placental imprinting is susceptible to environmental
perturbation.
4.3. Imprinted genes and the postnatal sequelae of altered in utero
development
The careful analysis of murine genetic models has demon-
strated that imprinted genes play critical roles in the development
of key metabolic organs with obvious consequences for postnatal
metabolic phenotype. This includes neuroendocrine and endocrine
organs involved in the control of homeostatic metabolic axes such
as the brain, pituitary, adrenal and pancreas; as well as tissues crit-
ical for energy storage and utilisation such as muscle, white and
brown adipose tissue and liver (Fig. 4) (reviewed in [66]). Per-
turbed development and postnatal function of these tissues is
thought to contribute to the metabolic sequelae of developmental
plasticity in response to in utero deprivation, but few studies have
investigated whether altered somatic imprinted gene expression
may be involved.
4.3.1. Imprinted genes and the pancreatic consequences of in utero
growth restriction
Pancreatic sensitivity to blood levels of glucose, insulin, IGF1
and other hormones is critically important for metabolic health.
The pancreas is a plastic organ, and early life events may play a role
in determining the capacity for adult pancreatic plasticity. Several
animal models have demonstrated altered pancreatic development
following in utero deprivation [67–70]. A group of imprinted genes
including Igf2, Rasgrf, Grb10, Neuronatin and Zac1 play key roles in
pancreatic development and maturation and may be involved in
the pathogenesis of these defects, although direct evidence of this
remains scanty.
Martin et al. [67] looked at the IGF axis and pancreatic function
in rats which had been protein restricted in utero during the lastweek of gestation. These rats have a phenotype similar to that of
local Igf2 overexpression [71] However, pancreatic Igf2 mRNA
expression was reduced and there was no change in hepatic or ser-
um levels of IGF2. Waterland and Garza [72] investigated the role
of nutrition on pancreatic maturation by altering rat litter size dur-
ing lactation. Both overnourished and undernourished animals had
impaired pancreatic islet glucose-stimulated insulin secretion.
Expression of Neuronatin was found to be signiﬁcantly reduced in
the overnourished individuals. Given the phenotypic similarities
with an in vitro siRNA knockdown [73], reduced Neuronatin expres-
sion in this model may have contributed to the insulin secretory
defects. However, interpretation of these data in the context of
the whole pancreatic transcriptome is required to determine
whether imprinted genes as a group are uniquely susceptible in
the pancreas to environmental perturbation. Convincing evidence
for the role of progressive reductions in pancreatic expression of
the key transcription factors Hnf4a and Pdx1 following compro-
mised early life conditions suggest that this may be unlikely
[69,70].
4.3.2. Imprinted genes in brain development and the central control of
metabolic axes
The brain is perhaps the most plastic organ of the body, capable
of remarkable feats of learning and memory which involve rapid
and widespread alterations of neuronal architecture and biochem-
istry. The majority of imprinted genes show high expression in the
brain and many are imprinted only here [our observations, 74].
Furthermore, the human congenital imprinting syndromes, for
example Prader–Willi syndrome (PWS) and Angelman syndrome
(AS), are all characterised by neurological and behavioural impair-
ments and learning difﬁculties, indicating the importance of
imprinting in brain development and function [75]. Stress or depri-
vation in utero and negative experiences early in life have been
associated in humans and animals with lasting changes in behav-
iour and emotionality and various psychiatric diseases [76]. Hot-
spots of imprinted gene expression are found in many areas
critical for motivation, emotion and reward, such as the brainstem
monoaminergic nuclei, the amygdala, nucleus accumbens and ven-
tral tegmental area (our observations, [74,77]). While there has
been much speculation on the possible role of imprinted genes in
these areas and hence in psychiatric illness, direct evidence of this
is sparse [78,79]. However Dlk1 and Grb10 have recently been
shown to be involved in the development of the midbrain dopami-
nergic population [80], while loss of Magel2 is associated with de-
fects in serotonergic signalling [81].
There is increasing evidence that developmental plasticity alters
the central regulation of homeostatic axes such as those involved in
control of blood volume, stress susceptibility and energy balance
[82–84].Many imprintedgenes showhighexpression inkey compo-
nents of the hypothalamo-pituitary axis (our observations; [74,85])
and although genetic mouse models of altered dosage at the Dlk1-
Dio3, Peg3 and Gnas loci show altered ‘‘set points’’ of metabolic axes
there is, to our knowledge, currently no data linking changes in the
early life environment with changes in the central nervous system
expression of imprinted genes [86–89].
5. Concluding remarks
Dosage control at imprinted loci is essential for successful
embryonic development. The temporal dynamics of acquisition of
imprinted expression at certain loci coincide with cellular differen-
tiation or lineage restriction events and the abnormal silencing of a
cluster of imprinted non-coding RNAs has been associated with re-
duced developmental potential of iPSCs [13]. Conversely, recent
data suggests that the highly selective and regulated relaxation
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some stem cell populations [14]. Furthermore, loss of imprinting
and altered imprinted gene expression dosage has been associated
with neoplastic transformation [21]. This leads us to suggest that
imprinting may be associated with the control of cellular develop-
mental plasticity. The investigation of the temporal dynamics of
imprinting in vivo during early development and in further tis-
sue-speciﬁc stem cell populations is required to determine the ex-
tent of the physiological role of imprinted gene expression in
cellular developmental plasticity.
It has been proposed that imprinted genes may be more suscep-
tible to dosage perturbation due to early life environmental chal-
lenges, and therefore that they may play a key role in the plastic
developmental response of an organism to the early life environ-
ment. However, we propose that the opposite may be true, that
imprinting genes may be protected from or may be less susceptible
to such environmental perturbation. To properly test such hypoth-
eses, the expression of imprinted genes in the context of the whole
transcriptome response to environmental challenge during early
life must be assessed, and such data is currently lacking. Most
studies have been hampered by low sample size, but there is
emerging evidence that genes such as Phlda2 may be involved in
altered placental development associated with intra uterine
growth restriction. However, untangling cause and effect in such
a morphologically plastic tissue is complicated. Where there is
some evidence of altered expression of imprinted genes in devel-
opmental plasticity, this is generally not associated with substan-
tial relaxation of imprinting, and does not consistently correlate
with changes in DNA methylation, implicating transcription-factor
mediated mechanisms, rather than loss of imprinting. Therefore,
modulation of gene dosage through loss of imprinting, as a devel-
opmental mechanism, may be rare, and any mechanism which re-
quires the action of the canonically repressed allele is likely to be
highly regulated.References
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